NEW YORK ( TheStreet) -- Qiagen (Nasdaq: QGEN) hit a new 52-week low Wednesday as it is currently trading at $12.93, below its previous 52-week low of $12.98 with 183,771 shares traded as of 9:30 a.m. ET. Average volume has been 2.2 million shares over the past 30 days. Qiagen has a market cap of $3.1 billion and is part of the health care sector and drugs industry. Shares are down 32% year to date as of the close of trading on Tuesday. QIAGEN N.V., through its subsidiaries, provides sample and assay technologies. The company has a P/E ratio of 21.8, below the average drugs industry P/E ratio of 23.8 and above the S&P 500 P/E ratio of 17.7.
- Practice your QGEN trading strategies and win cash in our stock game.